MedPath

A randomized trial to compare the single or double chest tube applications after pulmonary lobectomy

Not Applicable
Conditions
Postsurgical state after pulmonary lobectomy
Registration Number
JPRN-UMIN000009661
Lead Sponsor
Department of Thoracic Surgery, Kanazawa Medical University
Brief Summary

A total of 108 patients were registered in the study. There were no significant differences in the age, gender, pathological stage or histological type between two groups. Since the residual lung expansion was good in both groups, there were no patients who needed thoracentesis. There were no significant differences in the number of cases with pleurodesis, the amount/duration of drainage or the pain of the patients between two groups. Since PD1 has advantages in saving cost and time and in low risk of transcutaneous infection, PD1 is appropriate after pulmonary lobectomy by VATS and by open thoracotomy.

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
82
Inclusion Criteria

Not provided

Exclusion Criteria

After pneumonectomy In the condition where massive air leakage or massive bleeding is expected

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath